469 related articles for article (PubMed ID: 28573892)
1. Acute myeloid leukemia in the elderly: therapeutic options and choice.
Webster JA; Pratz KW
Leuk Lymphoma; 2018 Feb; 59(2):274-287. PubMed ID: 28573892
[TBL] [Abstract][Full Text] [Related]
2. Maintenance therapy for acute myeloid leukemia: sustaining the pursuit for sustained remission.
Shallis RM; Podoltsev NA
Curr Opin Hematol; 2021 Mar; 28(2):110-121. PubMed ID: 33394722
[TBL] [Abstract][Full Text] [Related]
3. Selecting initial treatment of acute myeloid leukaemia in older adults.
Podoltsev NA; Stahl M; Zeidan AM; Gore SD
Blood Rev; 2017 Mar; 31(2):43-62. PubMed ID: 27745715
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Elderly Patients With Acute Myeloid Leukemia.
Thomas X; Le Jeune C
Curr Treat Options Oncol; 2017 Jan; 18(1):2. PubMed ID: 28144802
[TBL] [Abstract][Full Text] [Related]
5. Post-remission therapy of adults aged 60 and older with acute myeloid leukemia in first complete remission: role of treatment intensity on the outcome.
Bouchacourt B; Hospital MA; Zemmour C; Rey J; d'Incan E; Charbonnier A; Mohty B; Saillard C; Bonnet S; Collignon A; Gelsi-Boyer V; Mozziconacci MJ; Blaise D; Vey N
Ann Hematol; 2020 Apr; 99(4):773-780. PubMed ID: 32088745
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of elderly de novo acute myeloid leukemia treated by a risk-adapted approach based on age, comorbidity, and performance status.
Yoon JH; Cho BS; Kim HJ; Kim JH; Shin SH; Yahng SA; Lee SE; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Am J Hematol; 2013 Dec; 88(12):1074-81. PubMed ID: 23983148
[TBL] [Abstract][Full Text] [Related]
7. Postremission therapy with repeated courses of high-dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long-term outcome in European leukemia net favorable and intermediate-risk acute myeloid leukemia.
Borlenghi E; Cattaneo C; Cerqui E; Archetti S; Bertoli D; Bellotti D; Gramegna D; Soverini G; Oberti M; Schieppati F; Pagani C; Passi A; Sciumé M; Farina M; Carbone C; Crippa C; Dalceggio D; Tucci A; Rossi G
Hematol Oncol; 2020 Dec; 38(5):754-762. PubMed ID: 32950042
[TBL] [Abstract][Full Text] [Related]
8. Initial therapy for acute myeloid leukemia in older patients: principles of care.
Bhatt VR; Gundabolu K; Koll T; Maness LJ
Leuk Lymphoma; 2018 Jan; 59(1):29-41. PubMed ID: 28573900
[TBL] [Abstract][Full Text] [Related]
9. Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
Ferrara F
Hematol Oncol; 2014 Mar; 32(1):1-9. PubMed ID: 23512815
[TBL] [Abstract][Full Text] [Related]
10. Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients.
Jackson K; Kennedy G; Mollee P; Marlton P; Morris K
Asia Pac J Clin Oncol; 2014 Sep; 10(3):246-54. PubMed ID: 24673966
[TBL] [Abstract][Full Text] [Related]
11. Standard-Intensity Induction and Intermediate/High-Dose Cytarabine Consolidation Can Improve Survival for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Cohort Study.
Wang L; Zhao N; Zhou L; Tong J; Xue L; Zhang L; Han Y; Wang X; Geng L; Tang B; Liu H; Zhu W; Cai X; Liu X; Zhu X; Sun Z; Zheng C
Clin Interv Aging; 2022; 17():55-64. PubMed ID: 35082491
[TBL] [Abstract][Full Text] [Related]
12. An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic Medical Records From US Community Oncology Practices.
Ma E; Bonthapally V; Chawla A; Lefebvre P; Swords R; Lafeuille MH; Fortier J; Emond B; Duh MS; Dezube BJ
Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):625-636.e3. PubMed ID: 27686689
[TBL] [Abstract][Full Text] [Related]
13. [Acute leukemia in adults].
Eigendorff E; Hochhaus A
Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
[TBL] [Abstract][Full Text] [Related]
14. [Russian experts' clinical guidelines for acute myeloid leukemia treatment in patients less than 60 years of age].
Savchenko VG; Parovichnikova EN; Afanas'ev BV; Gritsaev SV; Semochkin SV; Bondarenko SN; Troitskaia VV; Sokolov AN; Kuz'mina LA; Kliasova GA; Baranova OIu; Lapin VA; Konstantinova TS; Samoĭlova OS; Kaporskaia TS; Shatokhin SV
Ter Arkh; 2014; 86(7):4-13. PubMed ID: 25314772
[TBL] [Abstract][Full Text] [Related]
15. Are we curing more older adults with acute myeloid leukemia with allogeneic transplantation in CR1?
Finn LE; Foran JM
Curr Opin Hematol; 2016 Mar; 23(2):95-101. PubMed ID: 26825695
[TBL] [Abstract][Full Text] [Related]
16. Recent developments in the treatment of older individuals with acute myeloid leukemia: 2014.
Michaelis LC; Erba HP
Curr Opin Hematol; 2015 Mar; 22(2):108-15. PubMed ID: 25603478
[TBL] [Abstract][Full Text] [Related]
17. [Acute myeloid leukemia of the elderly: recent progresses in therapy].
Yamauchi T
Rinsho Ketsueki; 2018; 59(6):735-740. PubMed ID: 29973453
[TBL] [Abstract][Full Text] [Related]
18. Consolidation therapy with decitabine and intermediate-dose cytarabine followed by HLA-mismatched peripheral blood stem cells infusion for older patients with acute myeloid leukemia in first remission.
Li WY; Wang Y; Chen SN; Qiu HY; Fu ZZ; Wu DP; Sun AN
Leuk Lymphoma; 2018 Jul; 59(7):1652-1658. PubMed ID: 29043875
[TBL] [Abstract][Full Text] [Related]
19. Current and emerging therapies for acute myeloid leukemia.
Robak T; Wierzbowska A
Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
[TBL] [Abstract][Full Text] [Related]
20. Revisiting maintenance therapy in acute myeloid leukemia with novel agents.
Canaani J; Luger SM
Curr Opin Hematol; 2016 Mar; 23(2):175-80. PubMed ID: 26766539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
